Segaert MF, De Soete C, Vandewiele I, Verbanck J
Drug-interaction-induced rhabdomyolysis
Nephrol Dial Transplant
(Sep) 11:1846-1847 1996

Cyclosporine and simvastatin are both known to induce elevated CPK levels,
and sometimes cause
rhabdomyolysis when used in combination. Cyclosporin inhibits degradation of
simvastatin,
accentuating the risk of using these drugs together. In this paper, both
drugs were used together
without adverse effect for 3 years, but severe rhabdomyolysis developed after
addition of
itraconazole (for Alternaria fungus nose infection. Serum simvastatin
levels were 22 and 26
ng/ml, of the lactone and acid form, respectively, ten times higher than in
normal controls. To
test the hypothesis that itraconazole could increase simvastating levels, a
normal
hypercholesterolemic volunteer was given simvastatin. Challenge with
itraconazole caused a marked
elevation of serum simvastatin levels.
Comment: The clinical message is, that itraconazole should not be used
with either
simvastatin or lovastatin, unless the dose of the latter is markedly
reduced.
(John T. Daugirdas, M.D., University of Illinois at Chicago)